|
COIL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.379000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.150200E-01 |
| Normal-vs-Stage2 |
8.854600E-01 |
| Normal-vs-Stage3 |
1.727960E-01 |
| Normal-vs-Stage4 |
1.602770E-01 |
| Stage1-vs-Stage2 |
5.297200E-01 |
| Stage1-vs-Stage3 |
1.507870E-02 |
| Stage1-vs-Stage4 |
2.298300E-02 |
| Stage2-vs-Stage3 |
3.779400E-01 |
| Stage2-vs-Stage4 |
3.898800E-01 |
| Stage3-vs-Stage4 |
9.517800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.748600E-01 |
| Normal-vs-AfricanAmerican |
2.904400E-01 |
| Normal-vs-Asian |
2.298000E-01 |
| Caucasian-vs-AfricanAmerican |
3.344000E-01 |
| Caucasian-vs-Asian |
2.629600E-01 |
| AfricanAmerican-vs-Asian |
1.491750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.251200E-01 |
| Normal-vs-Female |
4.324600E-01 |
| Male-vs-Female |
2.117800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.267800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.810200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.345400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.076200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.276400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.926800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.658800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.125400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.365200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.513600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.629600E-02 |
| Normal-vs-Grade 2 |
1.619370E-01 |
| Normal-vs-Grade 3 |
1.822610E-01 |
| Normal-vs-Grade 4 |
1.805590E-02 |
| Grade 1-vs-Grade 2 |
2.925400E-01 |
| Grade 1-vs-Grade 3 |
1.067830E-02 |
| Grade 1-vs-Grade 4 |
2.541100E-03 |
| Grade 2-vs-Grade 3 |
5.415800E-04 |
| Grade 2-vs-Grade 4 |
2.211300E-04 |
| Grade 3-vs-Grade 4 |
1.343760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.397910E-02 |
| Normal-vs-ccB subtype |
6.080100E-02 |
| ccA subtype-vs-ccB subtype |
1.99359999952797E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.664000E-01 |
| Normal-vs-N1 |
8.483800E-01 |
| N0-vs-N1 |
9.240400E-01 |
|
|
